Norovirus has emerged as the leading cause of gastroenteritis - inflammation of the stomach and intestines - in children younger than 5 years, according to a new study.
The Food and Drug Administration has approved a new drug made by Bayer HealthCare Pharmaceuticals for treating tumors of the digestive system, the agency said Monday.
